Cargando…
P826: FACTOR D INHIBITION WITH ORAL BCX9930 LEADS TO SUSTAINED CONTROL OF HEMOLYSIS AND SYMPTOMS OVER 48 WEEKS IN SUBJECTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA INADEQUATELY CONTROLLED ON C5 INHIBITORS
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430168/ http://dx.doi.org/10.1097/01.HS9.0000846188.51290.75 |
| _version_ | 1784779679531532288 |
|---|---|
| author | Kulasekararaj, A. Füreder, W. McDonald, A. Malherbe, J. L. R. Gandhi, S. Collins, D. Cornpropst, M. Dobo, S. Farmer, M. K. Kargl, D. Sheridan, W. Griffin, M. Risitano, A. |
| author_facet | Kulasekararaj, A. Füreder, W. McDonald, A. Malherbe, J. L. R. Gandhi, S. Collins, D. Cornpropst, M. Dobo, S. Farmer, M. K. Kargl, D. Sheridan, W. Griffin, M. Risitano, A. |
| author_sort | Kulasekararaj, A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430168 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94301682022-08-31 P826: FACTOR D INHIBITION WITH ORAL BCX9930 LEADS TO SUSTAINED CONTROL OF HEMOLYSIS AND SYMPTOMS OVER 48 WEEKS IN SUBJECTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA INADEQUATELY CONTROLLED ON C5 INHIBITORS Kulasekararaj, A. Füreder, W. McDonald, A. Malherbe, J. L. R. Gandhi, S. Collins, D. Cornpropst, M. Dobo, S. Farmer, M. K. Kargl, D. Sheridan, W. Griffin, M. Risitano, A. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430168/ http://dx.doi.org/10.1097/01.HS9.0000846188.51290.75 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Kulasekararaj, A. Füreder, W. McDonald, A. Malherbe, J. L. R. Gandhi, S. Collins, D. Cornpropst, M. Dobo, S. Farmer, M. K. Kargl, D. Sheridan, W. Griffin, M. Risitano, A. P826: FACTOR D INHIBITION WITH ORAL BCX9930 LEADS TO SUSTAINED CONTROL OF HEMOLYSIS AND SYMPTOMS OVER 48 WEEKS IN SUBJECTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA INADEQUATELY CONTROLLED ON C5 INHIBITORS |
| title | P826: FACTOR D INHIBITION WITH ORAL BCX9930 LEADS TO SUSTAINED CONTROL OF HEMOLYSIS AND SYMPTOMS OVER 48 WEEKS IN SUBJECTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA INADEQUATELY CONTROLLED ON C5 INHIBITORS |
| title_full | P826: FACTOR D INHIBITION WITH ORAL BCX9930 LEADS TO SUSTAINED CONTROL OF HEMOLYSIS AND SYMPTOMS OVER 48 WEEKS IN SUBJECTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA INADEQUATELY CONTROLLED ON C5 INHIBITORS |
| title_fullStr | P826: FACTOR D INHIBITION WITH ORAL BCX9930 LEADS TO SUSTAINED CONTROL OF HEMOLYSIS AND SYMPTOMS OVER 48 WEEKS IN SUBJECTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA INADEQUATELY CONTROLLED ON C5 INHIBITORS |
| title_full_unstemmed | P826: FACTOR D INHIBITION WITH ORAL BCX9930 LEADS TO SUSTAINED CONTROL OF HEMOLYSIS AND SYMPTOMS OVER 48 WEEKS IN SUBJECTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA INADEQUATELY CONTROLLED ON C5 INHIBITORS |
| title_short | P826: FACTOR D INHIBITION WITH ORAL BCX9930 LEADS TO SUSTAINED CONTROL OF HEMOLYSIS AND SYMPTOMS OVER 48 WEEKS IN SUBJECTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA INADEQUATELY CONTROLLED ON C5 INHIBITORS |
| title_sort | p826: factor d inhibition with oral bcx9930 leads to sustained control of hemolysis and symptoms over 48 weeks in subjects with paroxysmal nocturnal hemoglobinuria inadequately controlled on c5 inhibitors |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430168/ http://dx.doi.org/10.1097/01.HS9.0000846188.51290.75 |
| work_keys_str_mv | AT kulasekararaja p826factordinhibitionwithoralbcx9930leadstosustainedcontrolofhemolysisandsymptomsover48weeksinsubjectswithparoxysmalnocturnalhemoglobinuriainadequatelycontrolledonc5inhibitors AT furederw p826factordinhibitionwithoralbcx9930leadstosustainedcontrolofhemolysisandsymptomsover48weeksinsubjectswithparoxysmalnocturnalhemoglobinuriainadequatelycontrolledonc5inhibitors AT mcdonalda p826factordinhibitionwithoralbcx9930leadstosustainedcontrolofhemolysisandsymptomsover48weeksinsubjectswithparoxysmalnocturnalhemoglobinuriainadequatelycontrolledonc5inhibitors AT malherbejlr p826factordinhibitionwithoralbcx9930leadstosustainedcontrolofhemolysisandsymptomsover48weeksinsubjectswithparoxysmalnocturnalhemoglobinuriainadequatelycontrolledonc5inhibitors AT gandhis p826factordinhibitionwithoralbcx9930leadstosustainedcontrolofhemolysisandsymptomsover48weeksinsubjectswithparoxysmalnocturnalhemoglobinuriainadequatelycontrolledonc5inhibitors AT collinsd p826factordinhibitionwithoralbcx9930leadstosustainedcontrolofhemolysisandsymptomsover48weeksinsubjectswithparoxysmalnocturnalhemoglobinuriainadequatelycontrolledonc5inhibitors AT cornpropstm p826factordinhibitionwithoralbcx9930leadstosustainedcontrolofhemolysisandsymptomsover48weeksinsubjectswithparoxysmalnocturnalhemoglobinuriainadequatelycontrolledonc5inhibitors AT dobos p826factordinhibitionwithoralbcx9930leadstosustainedcontrolofhemolysisandsymptomsover48weeksinsubjectswithparoxysmalnocturnalhemoglobinuriainadequatelycontrolledonc5inhibitors AT farmermk p826factordinhibitionwithoralbcx9930leadstosustainedcontrolofhemolysisandsymptomsover48weeksinsubjectswithparoxysmalnocturnalhemoglobinuriainadequatelycontrolledonc5inhibitors AT kargld p826factordinhibitionwithoralbcx9930leadstosustainedcontrolofhemolysisandsymptomsover48weeksinsubjectswithparoxysmalnocturnalhemoglobinuriainadequatelycontrolledonc5inhibitors AT sheridanw p826factordinhibitionwithoralbcx9930leadstosustainedcontrolofhemolysisandsymptomsover48weeksinsubjectswithparoxysmalnocturnalhemoglobinuriainadequatelycontrolledonc5inhibitors AT griffinm p826factordinhibitionwithoralbcx9930leadstosustainedcontrolofhemolysisandsymptomsover48weeksinsubjectswithparoxysmalnocturnalhemoglobinuriainadequatelycontrolledonc5inhibitors AT risitanoa p826factordinhibitionwithoralbcx9930leadstosustainedcontrolofhemolysisandsymptomsover48weeksinsubjectswithparoxysmalnocturnalhemoglobinuriainadequatelycontrolledonc5inhibitors |